It was a pleasure to be invited by the french association France Immersive Learning in the meeting “Immersive technology in health”. We presented our own uses of VR (virtual reality) and AR (augmented reality) in two different domains. First, we used AR for the installation of our robotic platform, in Read more…
As you may now, in HCS Pharma we strongly believe that the critical point of the human health evolution in next years is the in vitro 3D cell culture, especially for complex diseases like cancer [1]. It’s why we work hard on our exclusive BIOMIMESYS® technology. As experts in HCS and cell imaging, we must master all the process : 3D biological models, 3D cell culture, volumetric pictures acquisition, 3D reconstruction and segmentation of cells and ECM compounds, 3D parameters extraction and, of course, biological interpretations. As explained in our VisuAI R&D project, the 3D reconstruction and segmentation step is not simple.
In HCS Pharma, we have already talked about Artificial Intelligence (AI) and the way it is useful in picture analysis. AI can obviously be used for many endeavours, like the shortening of drug discovery timeline as it is explained in the article “Deep learning enables rapid identification of potent DDR1 Read more…
Since 2 years, we saw AI (Artificial Intelligence) spreading in more and more domains, sometime presented as the “panacée” of all problems. In healthcare, and especially in drug discovery, many announces are done but, to be honest, very few results are published. In the article, the author explains the advantages Read more…
Many news have been published since 2 or 3 years about Artificial Intelligence (AI) and Machine Learning / Deep Learning use in picture analysis. Lastly, Microsoft published an astonishing article where they explained that this technology is so powerful that the government needs to regulate it, especially for face recognition. Read more…